GeoVax Labs, Inc.
GOVX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000832489
No open-market purchases or sales by GeoVax Labs, Inc. insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $625.5K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in GeoVax Labs, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- −5 vs. Q4 2023
- Shares held
- 240.8K
- +31.7K (+15.2%) vs. Q4 2023Converted for a 1-for-15 split
- Total value
- $481.2K
- −$650.6K (−57.5%) vs. Q4 2023
- New holders
- 0
- 5 more added
- Sold out
- 5
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $625.5K |
| Q1 2026 | 16 | $459.6K |
| Q4 2025 | 22 | $468.7K |
| Q3 2025 | 21 | $919.3K |
| Q2 2025 | 21 | $478.3K |
| Q1 2025 | 18 | $1.24M |
| Q4 2024 | 19 | $715.6K |
| Q3 2024 | 17 | $1.08M |
| Q2 2024 | 12 | $619.1K |
| Q1 2024 | 11 | $481.2K |
| Q4 2023 | 16 | $1.13M |
| Q3 2023 | 14 | $797.6K |
| Q2 2023 | 16 | $886.0K |
| Q1 2023 | 17 | $1.07M |
| Q4 2022 | 20 | $1.35M |
| Q3 2022 | 23 | $3.39M |
| Q2 2022 | 19 | $2.02M |
| Q1 2022 | 16 | $1.09M |
| Q4 2021 | 15 | $1.68M |
| Q3 2021 | 13 | $1.98M |
| Q2 2021 | 10 | $1.99M |
| Q1 2021 | 10 | $1.22M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding GeoVax Labs, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 178,000 | $356.0K | 0.01% | +69,566+64.2% | AddedConverted for a 1-for-15 split |
| BlackRock Inc. | 27,565 | $55.1K | 0.00% | 00.0% | UnchangedConverted for a 1-for-15 split |
| Vanguard Group Inc | 19,239 | $38.5K | 0.00% | −29,324−60.4% | ReducedConverted for a 1-for-15 split |
| Geode Capital Management, LLC | 11,161 | $21.9K | 0.00% | −365−3.2% | ReducedConverted for a 1-for-15 split |
| Tower Research Capital LLC (TRC) | 4,471 | $8.94K | 0.00% | +3,787+553.3% | AddedConverted for a 1-for-15 split |
| Wells Fargo & Company | 217 | $434 | 0.00% | −63−22.6% | ReducedConverted for a 1-for-15 split |
| Morgan Stanley | 120 | $240 | 0.00% | −16−11.8% | ReducedConverted for a 1-for-15 split |
| Global Retirement Partners, LLC | 27 | $54 | 0.00% | +0+1.0% | AddedConverted for a 1-for-15 split |
| JPMorgan Chase & Co | 1 | $2 | 0.00% | −2−67.4% | ReducedConverted for a 1-for-15 split |
| FMR LLC | 1 | $2 | 0.00% | +1+275.0% | AddedConverted for a 1-for-15 split |
| Royal Bank of Canada | 4 | $0 | 0.00% | +1+20.0% | AddedConverted for a 1-for-15 split |
| State Street Corp | 0 | $0 | 0.00% | −6,529−100.0% | Sold outConverted for a 1-for-15 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −2,281−100.0% | Sold outConverted for a 1-for-15 split |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −1,913−100.0% | Sold outConverted for a 1-for-15 split |
| Welch & Forbes LLC | 0 | $0 | 0.00% | −1,133−100.0% | Sold outConverted for a 1-for-15 split |
| Bank of America Corp | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-15 split |